Prognostic factors for the outcome of childhood asthma in adolescence Ruurd Jan Roorda
The incidence of asthma, particularly in childhood, is rising."1 Although the precise reasons for this increase are unknown, it is likely that a number of environmental factors are at least partly responsible. To date, the most likely explanation for the increased prevalence of asthma is an increased allergen load in the environment causing increased airway responsiveness in atopic children. 5 The increased prevalence of asthma in children may well have serious implications for adults if patients continue to have asthma symptoms in adulthood, although, as yet, only a small number of studies have shown that the prevalence of asthma rises in young adults. 6 Over the past few decades the natural evolution of asthma from childhood to adulthood has been the subject of many studies.7-5 It was long believed that the prognosis for asthma originating in infancy or childhood was good, and that in most patients the symptoms would resolve by the age ofpuberty. However, a review of the literature shows that not all patients become asymptomatic in adulthood. In fact, asthma symptoms persist in 30-80% of adult patients. Although epidemiological studies have shown a fair chance of either "remission" or a reduction in asthma symptoms between the ages of 10 and 20 years, 5"I and most population based and clinical studies have also shown a reduction in asthma symptoms with age, the relapse rate after a symptom-free interval is known to be relatively high.6062 It has also been shown that, even in the absence of asthma symptoms, subjects may Length of follow up A further problem in the study of long term prognosis of asthma is the relatively short periods of observation employed in many studies. Asthma may vary spontaneously over time and periods of remission are often followed by relapses. An important problem, therefore, is that of "complete remission" which has been defined as complete freedom from asthma symptoms during a period of between two and five years, or the absence of symptoms at the time of the final assessment. It is now well known that asthma symptoms may recur after much longer periods of time. It is therefore likely that a considerable number of patients thought to be in complete remission remain latent asthmatics until the symptoms are triggered again. The majority of clinical studies do not show a significant negative effect on the prognosis of early onset asthma although the disease may be severe in these children.'2132127435' In some studies early onset of symptoms has been associated with an unfavourable outcome.20 35 54 This does not contradict the favourable prognosis for children with wheezing during the early years of life found in epidemiological studies since this group of patients includes a number of children with wheezy illnesses other than asthma. A higher asthma symptom score in childhood, which represents more severe asthma, is a well known risk factor for the persistence of asthma in adulthood.'727435' The clinical severity of asthma in childhood is therefore an important predictor of asthma persistence in adulthood. ATOPIC 
MANIFESTATIONS
In at least 75% of asthmatic children asthma is associated with allergy to inhaled allergens and a family history of allergy.
Few long term studies have considered the influence of family history on the long term prognosis of childhood asthma. Ryssing and Flensborg'8 and Martin et a13' agree that a positive family history for atopy is associated with an unfavourable asthma prognosis. However, in other studies family history was found not to affect asthma prognosis adversely.253447
If family history does not determine individual asthma prognosis the implication is that the severity of asthma is not genetically determined, even if the individual has a genetic predisposition to the disease. Therefore, environmental factors are probably the most important factors in the clinical expression and prognosis of asthma.
Due to cumulative exposure to allergens, skin reactivity to inhaled allergens increases with age and peaks in young adults aged between 25 and 34 years of age.69 Many studies have shown that both the number of positive skin tests and weal diameter increase with age. In most of the studies the increase in skin reactivity, as expressed by the number of positive skin tests, appears to be independent of the progress of asthma in children. 24273070 Some studies have shown a favourable prognosis in children with negative skin tests or positive tests to a small number of allergens.43 These findings might, however, be influenced by selection criteria, as almost all of the children included in these studies were allergic.
In our own study, in which the study population was stratified according to the degree of skin reactivity in childhood (sum score of the semiquantitative expression ofweal diameters), those subjects who had the lowest childhood total skin test score were found to have the lowest incidence of asthma symptoms in adulthood. Mean eosinophil count in childhood was slightly but not significantly higher in subjects with persistent symptoms in adulthood. 4550 Mazon et al55 studied the effects of sensitivity to allergens (as assessed by skin testing or RAST) on the persistence of asthma. Although the follow up interval was rather short (mean 63 months) and the ages of the children included in the study were not given, a significant association with persistent symptoms and sensitisation to house dust mite, moulds, pollen, and milk protein was demonstrated.
No data are available to date on the value of either total or specific serum IgE levels in the assessment of asthma prognosis. In some studies children with normal or only slightly raised IgE values ("intrinsic asthma") were labelled as having the most troublesome disease.3437
Although epidemiological studies suggest that the presence of allergic eczema and/or rhinitis with asthma has a negative effect on asthma prognosis,487' clinical studies have proved to be inconclusive. Some studies found no predictive effect,46 52 A relationship exists between atopy or specific (allergic) bronchial hyperresponsiveness and non-specific bronchial hyperresponsiveness to, for example, histamine or methacholine. However, although atopy and bronchial hyperresponsiveness are interrelated, they appear to act independently with respect to asthma prognosis.
Gerritsen46 studied the prognostic value of the type of response to specific (house dust) inhalation provocation in childhood. The study indicated that the prognosis for subjects who had no response in childhood was better than for those subjects who did exhibit a response.
However, there were no significant differences in the prognosis for children with either an early, late, or dual asthmatic response.
Non-specific bronchial hyperresponsiveness may presage asthma.7374 The degree of nonspecific bronchial hyperresponsiveness may vary greatly from time to time within the asthmatic individual. As the asthmatic child matures bronchial responsiveness may decrease. closer to normal the longer the patient was free of wheezing),526578 while their childhood level was normal or only mildly reduced. In an Australian follow up study subjects who still had severe symptoms in adulthood had the most serious disturbance of pulmonary function in childhood and the steepest decline of pulmonary function towards adulthood. FEV, levels below the fifth percentile at 10 or 14 years of age were associated with more troublesome asthma at the age of 21 years. 38 Studies in children consistently show a higher prevalence of asthma in boys . . ., but in general the prognosis for women is worse than it is for men.
DIFFERENCES IN SEX WITH RESPECT TO ASTHMA
Studies in children consistently show a higher prevalence of asthma in boys, the prevalence before puberty being at least twice as high in boys than in girls. Symptoms may also start at a younger age in boys.
The higher prevalence of asthma in boys may be caused by a combination of factors. "Host susceptibility" may be greater in boys, and a higher incidence of respiratory distress syndrome and other respiratory illnesses suggest that boys may have more vulnerable airways. The absolute peripheral airway diameter is smaller in young boys than it is in young girls, especially in the first 18 months of life.7980 Differences in the prevalence of asthma may also be influenced by differences in the size of the airways relative to size of the lungs. The prevalence of allergic phenomena is also higher in boys.458' Furthermore, some studies have demonstrated a higher prevalence of bronchial hyperresponsiveness in boys. [82] [83] [84] The predominance of boys among asthmatic subjects gradually diminishes until puberty when a higher incidence of new cases of asthma is found in girls,28 and after the age of 20 years the incidence of asthma is higher in women than in men. In most studies in young asthmatic adults the male:female ratio is about 1:1-5. Hospital admission rates and morbidity rates after the age of 40 years are also significantly higher in women than in men. Not only is the proportion of women with current complaints in adulthood higher than in men, symptom scores are also increased. In general, therefore, the prognosis for women is worse than it is for men.'2 28404451 85 86 The cause of the differences between the sexes is unknown and it is somewhat surprising that this topic is not addressed more fully in the literature.
In the 1960s it was postulated that hormonal differences might be responsible for the differences in asthma severity between the sexes.87 Hormones may influence airway inflammation, airway smooth muscle function, and vascular integrity. The higher levels of morbidity due to asthma in women may also be related to differences in the rate of lung growth between the sexes and a deterioration of pulmonary function with age. Airway diameter and parenchymal size may also affect morbidity due to asthma as airway responsiveness is related to airway size. Women possess smaller lungs than men and this may explain their increased airway responsiveness, although the higher level of airway responsiveness cannot completely explain the higher level of morbidity due to asthma among women.
Both active and passive smoking influence the outcome of childhood asthma. However, few long term clinical studies have been carried out on the influence of passive smoking on the prognosis of asthma in children. There is evidence that a substantial proportion of children with asthma, especially boys, have worsening symptoms and reduced pulmonary function when passively exposed to tobacco smoke. 88 The effects of passive smoking is likely to be more significant in population based studies than in clinical studies. Tager89 demonstrated that inhaled smoke, either actively or passively, renders asthmatic children more susceptible to irreversible limitation of the small airways.
However, two prospective studies in young adults in the Netherlands found no significant effects on asthma symptoms among active smokers,405' although in one of the studies the cigarette smoking (as measured by the number ofpack years) adversely affected the FEV, levels in adult men.5' The lack of negative health effects may be explained by the so-called "healthy smoker" effect in which mildly asthmatic individuals with relatively few symptoms and limited bronchial responsiveness are able to start cigarette smoking. The proportion of asthmatics who were active smokers was surprisingly high compared with the proportion of smokers in the Dutch population as a whole. However, neither of these studies included a sufficiently long follow up period and the number of pack years was too small to demonstrate all of the potential effects of cigarette smoking on the prognosis for asthma sufferers.90 The same limitations may explain the lack of a negative effect of cigarette smoking found in the Australian follow up study.38 TREATMENT Asthma is considered to be an inflammatory disease of the airways and anti-inflammatory agents are currently the mainstay of asthma treatment. Few long term studies on the influence of such treatment on asthma prognosis have been published. A large prospective multicentre study in 116 children compared treatment for 22 months with either budesonide in combination with salbutamol (each 600 jtg daily), or salbutamol and placebo. Children who received inhaled corticosteroids showed a significant reduction in asthma symptoms within the first few months of the study, a slight increase in pulmonary function, and a reduction in airway responsiveness which still had not reached a plateau by the end of the study.9' In some of the children asthma symptoms had resolved (clinical remission for at least eight months). Lower symptom burden at baseline seemed to be the only predictor of patients likely to enter remission. 92 However, cessation of inhaled corticosteroid therapy led to recurrence of symptoms and a rapid deterioration of airway responsiveness.93 It may be concluded, therefore, that inhaled corticosteroid therapy cannot cure asthma, and that the underlying inflammatory process remains, even after a long period of treatment.
In a retrospective study carried out in Denmark maintenance prophylactic treatment with inhaled corticosteroids was compared with other treatment regimens in children. The study indicated that the earlier treatment with corticosteroids was begun following the diagnosis of asthma, the greater was the increase in pulmonary function (FEV, ml/year).94 Konig95 carried out a retrospective study to compare the effects of sodium cromoglycate with those of inhaled corticosteroids. A significant clinical improvement and improvement in pulmonary function were found in all of the children treated with anti-inflammatory agents, and there were no differences between agents. As properly matched and controlled prospective long term studies have not yet been published, it is not possible to evaluate the effects of any particular treatment for asthma. Nevertheless, the above studies suggest that early use of prophylactic asthma treatment may succeed in improving the prognosis for asthmatic children and may favour optimal lung growth throughout adolescence. Although the severity of asthma symptoms fluctuates with time, the inherited tendency towards respiratory symptoms never disappears and many teenagers who seem to be free of symptoms do, in fact, have persistent asthma. During symptom-free periods subclinical, but nevertheless significant, airways obstruction and/or bronchial hyperresponsiveness may be present. It is not unusual for adults who have been asymptomatic for a number of years to redevelop asthma symptoms. Indeed, much of the so-called adult onset asthma has its roots in childhood. Levison98 concluded that, in these subjects, it is often not the asthma that is outgrown but the paediatrician.
... it is often not the asthma that is outgrown but the paediatrician.
The more severe asthma is in childhood the more likely it is that the disease will persist in adulthood. A complete list ofthe characteristics of the disease in childhood, and the potential risk factors associated with an unfavourable prognosis, such as pulmonary function and bronchial responsiveness and markers of airway inflammation, is therefore needed.
As properly matched and controlled prospective long term studies have not been published it has not been possible to evaluate the effects on prognosis of any single class of antiasthma agent. Such studies are needed to find out if it is possible to alter the natural history of the disease. In theory modem asthma treatments, because they are able to improve symptoms and underlying disease phenomena, are also beneficial in the long term prognosis of childhood asthma.
Since compliance ... is low, a monitoring system is needed to guarantee adequate follow up and treatment during and beyond puberty.
The majority of patients with persistent asthma included in the currently available studies were not receiving adequate treatment.
Since compliance with therapeutic regimens in asthma, especially in adolescence, is low, a monitoring system is needed to guarantee adequate follow up and treatment during and beyond puberty.
